The groundbreaking decision is a win for harm reduction, though it also highlights absurd contradictions in the FDA's overall ...

Report with market evolution powered by AI - The global nicotine patch market size is estimated to grow by USD 494.1 million ...

RICHMOND, Va. The U.S. Food and Drug Administration (FDA) today authorized ZYN nicotine pouches making ZYN the first and only authorized nicotine pouch in the United States. The FDA’s ...

Introducing Journavx: the FDA-approved non-opioid, non-addictive drug for acute pain. A major breakthrough in pain medication ...

The FDA has approved a new type of painkiller that doesn't come with the risks of addiction and overdose associated with opioids.

The FDA has approved Journavx, a pain medication, offering a safer alternative to opioids. Learn about its benefits and side ...

The US Food and Drug Administration (FDA) is pushing to reduce the levels of nicotine in cigarettes and other combusted ...

Zydus received FDA approval to conduct a Phase 2b trial testing usnoflast, its oral therapy for ALS, in 210 patients.

Following an extensive scientific review, the U.S. Food and Drug Administration, FDA, authorized the marketing of 20 ZYN nicotine pouch products through the premarket tobacco product application ...

FDA approves Zyn nicotine pouches, including 10 flavors, as a safer option for adult smokers. The decision marks the first FDA authorization for nicotine pouches, which are tobacco-free. Advocates ...

FDA approves Zyn nicotine pouches, including 10 flavors, as a safer option for adult smokers. The decision marks the first FDA authorization for nicotine pouches, which are tobacco-free.